Big data: the next frontier for innovation in therapeutics and healthcare
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Advancements in genomics and personalized medicine not only effect healthcare delivery from patient and provider standpoints, but also reshape biomedical discovery. We are in the era of the '-omics', wherein an individual's genome, transcriptome, proteome and metabolome can be scrutinized to the finest resolution to paint a personalized biochemical fingerprint that enables tailored treatments, prognoses, risk factors, etc. Digitization of this information parlays into 'big data' informatics-driven evidence-based medical practice. While individualized patient management is a key beneficiary of next-generation medical informatics, this data also harbors a wealth of novel therapeutic discoveries waiting to be uncovered. 'Big data' informatics allows for networks-driven systems pharmacodynamics whereby drug information can be coupled to cellular- and organ-level physiology for determining whole-body outcomes. Patient '-omics' data can be integrated for ontology-based data-mining for the discovery of new biological associations and drug targets. Here we highlight the potential of 'big data' informatics for clinical pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 1×
“Additional interesting general outcomes from these approaches include the observations that the chemical space spanned by drugs does not necessarily correlate with biological activity [7], and that singular targets may not be sufficient to alter diseases [8].”
BackgroundLamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Shi, H., Hugo, W., Kong, X., Hong, A., Koya, R. C., Moriceau, G., Chodon, T., Guo, R., Johnson, D. B., Dahlman, K. B., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0642 · Cited by 982 · cited 1×
“Investigators are able to access this information to analyze differential expression patterns [11] .”
BackgroundPharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824 · cited 2×
“Similarly, Clayton et al. developed personalized pharmacometabolomics, where pre-dose urinary metabolite profiles are predictive of drug-induced hepatocellular toxicity [17] .”
Background
Cited by
Industry 4.0 and Health: Internet of Things, Big Data, and Cloud Computing for Healthcare 4.0
Aceto, G., Persico, V., & Pescapé, A. (2020) · Journal of Industrial Information Integration · doi:10.1016/j.jii.2020.100129 · Cited by 876
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723
Aceto, G., Persico, V., & Pescapé, A. (2018) · Journal of Network and Computer Applications · doi:10.1016/j.jnca.2018.02.008 · Cited by 504
Challenges and Opportunities of Big Data in Health Care: A Systematic Review
Kruse, C. S., Goswamy, R., Raval, Y., & Marawi, S. (2016) · JMIR Medical Informatics · doi:10.2196/medinform.5359 · Cited by 394
Drug Repurposing for Rare Diseases
Roessler, H. I., Knoers, N. V. A. M., van Haelst, M. M., & van Haaften, G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.01.003 · Cited by 269
Metadata
- Authors
- Issa, N. T., Byers, S. W., & Dakshanamurthy, S.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2014-04-07
- Volume
- 7
- Issue
- 3
- Pages
- 293-298
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W2095867591
- Cited by
- 92
- References
- 4
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Big data: the next frontier for innovation in therapeutics and healthcare. https://app.cochat.ai/papers/10.1586/17512433.2014.905201
- The paper
- Issa, N. T., Byers, S. W., & Dakshanamurthy, S. (2014). Big data: the next frontier for innovation in therapeutics and healthcare. Expert Review of Clinical Pharmacology. https://doi.org/10.1586/17512433.2014.905201
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.